Hypertension Diagnostics™, headquartered in
Eagan, Minnesota, was founded in July 1988 to develop a
proprietary blood pressure waveform analysis methodology as
a non-invasive means for measuring the elasticity of
large and small arteries. The company’s first product for
researchers was launched in August 1998. HD’s first
commercial product was launched in March 2001.
HD was purchased by CVC-HD, LLC in August
2011. CVC-HD, LLC is a leading cardiovascular prevention
diagnostics company located in Eagan, MN.
HD has developed proprietary blood pressure
waveform analysis technology which has been incorporated
into the design of several products:
These non-invasive Systems are capable of
measuring several hemodynamic parameters including arterial
compliance (that is, the elasticity of an individual's
arteries). Such measurements are useful to clinical
researchers studying cardiovascular interventions in
industry (for example, pharmaceutical manufacturers) and in
academic and medical centers.
The CVProfilor® Systems have a clinical
application due to their sensitivity to early arterial
changes which can determine if patients have potential
underlying vascular disease that might require more specific
diagnostic evaluation by physicians or other health care
professionals.
The CVProfilor® DO-2020 System, intended for
use by U.S. physicians to assess patients for vascular
disease, is a medical device cleared for marketing by the
FDA. The CVProfilor® MD-3000 System is available for
use by physicians and other health care professionals in
markets outside the U.S. and is CE Marked and is ISO 13485.
Today, over 650 CVProfilor® systems have
been sold in over 30 countries worldwide.
